Recommended Topic Related To:

Zemaira

"The U.S. Food and Drug Administration today approved Vimizim (elosulfase alfa), the first FDA-approved treatment for Mucopolysaccharidosis Type IVA (Morquio A syndrome). Morquio A syndrome is a rare, autosomal recessive lysosomal storage disease "...

Zemaira

Overdosage
Contraindications

OVERDOSE

No information available.

CONTRAINDICATIONS

Zemaira (alpha-proteinase inhibitor (human)) is contraindicated in individuals with a known hypersensitivity to any of its components. Zemaira (alpha-proteinase inhibitor (human)) is also contraindicated in individuals with a history of anaphylaxis or severe systemic response to A1-PI products. Individuals with selective IgA deficiencies who have known antibodies against IgA (anti-IgA antibodies) should not receive Zemaira (alpha-proteinase inhibitor (human)) , since these patients may experience severe reactions, including anaphylaxis, to IgA that may be present in Zemaira (alpha-proteinase inhibitor (human)) .

Last reviewed on RxList: 12/8/2004
This monograph has been modified to include the generic and brand name in many instances.

Overdosage
Contraindications
A A A

Report Problems to the Food and Drug Administration

 

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.


Women's Health

Find out what women really need.


NIH talks about Ebola on WebMD